Page last updated: 2024-10-28

hydroxyzine and Aggressive Systemic Mastocytosis

hydroxyzine has been researched along with Aggressive Systemic Mastocytosis in 1 studies

Hydroxyzine: A histamine H1 receptor antagonist that is effective in the treatment of chronic urticaria, dermatitis, and histamine-mediated pruritus. Unlike its major metabolite CETIRIZINE, it does cause drowsiness. It is also effective as an antiemetic, for relief of anxiety and tension, and as a sedative.
hydroxyzine : A N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively.

Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishii, K1
Miyoshi, H1
Akiyama, D1
Makita, T1
Sumikawa, K1
Murata, H1
Hara, T1

Other Studies

1 other study available for hydroxyzine and Aggressive Systemic Mastocytosis

ArticleYear
Anesthetic management of patients with systemic mastocytosis.
    Journal of clinical anesthesia, 2018, Volume: 50

    Topics: Adenomatous Polyposis Coli; Adult; Anaphylaxis; Anesthesia, General; Anesthetics; Colectomy; Epineph

2018